Skip to main content

Cell Reports Impact Factor

Cell Reports impact factor is 7.7. See the current rank, quartile, and what the number actually means before you submit.

Editorial processThe Manusights editorial team researches and maintains these guides using source review, field-specific analysis, and our documented editorial process.How we work

Journal evaluation

Want the full picture on Cell Reports?

See scope, selectivity, submission context, and what editors actually want before you decide whether Cell Reports is realistic.

Open Cell Reports GuidePrivate API processing. Your manuscript is not used to train models.Run my Free Readiness Scan
Metric context

A fuller snapshot for authors

Use Cell Reports's impact factor as one signal, then stack it against selectivity, editorial speed, and the journal guide before you decide where to submit.

Open full journal guide

What this metric helps you decide

  • Whether Cell Reports has the citation profile you want for this paper.
  • How the journal compares to nearby options when prestige or visibility matters.
  • Whether the citation upside is worth the likely selectivity and process tradeoffs.

What you still need besides JIF

  • Scope fit and article-type fit, which matter more than a high number.
  • Desk-rejection risk, which impact factor does not predict.
  • Timeline and cost context, including APCs like $5,790 USD.

CiteScore: 15.1. These longer-window metrics help show whether the journal's citation performance is stable beyond a single JIF snapshot.

Submission context

How authors actually use Cell Reports's impact factor

Use the number to place the journal in the right tier, then check the harder filters: scope fit, selectivity, and editorial speed.

Use this page to answer

  • Is Cell Reports actually above your next-best alternatives, or just more famous?
  • Does the prestige upside justify the likely cost, delay, and selectivity?
  • Should this journal stay on the shortlist before you invest in submission prep?

Check next

  • Acceptance rate and desk-rejection risk, because impact factor does not tell you if the journal is realistic.
  • First decision: 5 days median. Timeline matters if you are under a grant, job, or revision clock.
  • Publishing cost: $5,790 USD. Budget and institutional coverage can change the decision.

Acceptance-rate source check (October 21, 2026): We have not verified a current acceptance rate for Cell Reports. Check Elsevier’s journal catalog for the publisher’s current figure; an unverified figure does not mean the publisher reports none. Elsevier journal catalog.

Quick answer: Cell Reports has a 2025 Journal Impact Factor of 7.7 in the 2026 JCR release, with Q1 ranking and rank 44/204 in Cell Biology. Five-year JIF is 8.1. The IF dropped from 9.9 (2021) as pandemic citation patterns normalized.

Impact-factor source note

For Cell Reports, cite the impact factor with the Cell Biology rank, five-year JIF, CiteScore, APC, and timeline context shown here. Because Cell Press transfer-path decisions depend on more than the JIF, confirm Clarivate/JCR or the Cell Reports metrics page before formal use.

Cell Reports publishes complete, mechanistic biology that clears Cell Press editorial standards without requiring a field-reshaping discovery.

Cell Reports Impact Factor at a Glance

Metric
Value
Source
Impact Factor
7.7
2026 JCR release
5-Year JIF
8.1
2026 JCR release
JIF Without Self-Cites
6.7
2026 JCR release
Journal Citation Indicator
1.24
2026 JCR release
CiteScore
12.9
Scopus 2024
SJR
3.796
Scopus 2024
h-index
246
Scopus
Quartile
Q1 (Cell Biology, 44/204)
Clarivate
Cited Half-Life
5.4 years
2026 JCR release
Total Cites (2024)
101,811
2026 JCR release
Time to first editorial decision
5 days (median)
Cell Press
Review decision
37 days (median)
ScienceDirect journal insights
Submission to acceptance
See the ScienceDirect journal insights page
ScienceDirect
APC
~$5,790
Cell Press 2026
Articles/year
~1,338
2026 JCR release

The JCI of 1.24 contextualizes the 7.7 IF honestly. Cell Reports is cited about 24% more than the average journal when normalized across fields. It's a strong, reliable venue, but the JCI confirms it's not in the same citation tier as Cell (JCI ~8) or Nature Cell Biology.

The CiteScore of 12.9 running almost double the two-year IF reflects that Cell Reports papers keep accumulating citations past the initial window, typical for mechanistic biology where findings become reference points for subsequent work.

In our analysis of Cell Reports-targeted manuscripts, the named metric-reading failure pattern is treating the 7.7 impact factor as if it were a generic mid-tier signal. The Cell Press brand and STAR Methods requirements make the journal more demanding than many journals with similar IFs; the number should be read together with editorial process, methods transparency, and the Cell Press transfer pathway.

In practice, the 7.7 number is most useful as a calibration signal: it tells authors not to pitch the paper like a Cell submission, but also not to treat Cell Reports like a generic broad-scope open-access journal. The submission needs a complete Cell Press-style evidence package even when the citation metric looks closer to specialty biology journals.

Year-by-Year Impact Factor Trend

Year
Impact Factor
Context
2025
7.7
2026 JCR release
2024
6.9
Post-pandemic steady state
2023
7.7
Normalizing
2022
8.8
Pandemic tail
2021
9.9
Pandemic peak
2020
9.4
COVID-era lift
2019
8.1
Pre-pandemic baseline
2018
8.0
-
2017
8.3
-

The pre-pandemic baseline was 8.0-8.3. The current 7.7 is actually below the pre-pandemic range, which suggests either a real competitive shift (more journals competing for the same biology papers) or a citation-pattern change (shorter citation windows across all journals). The five-year JIF of 8.1 being higher confirms that Cell Reports papers do continue accumulating citations, the two-year number understates the journal's citation influence.

What 7.7 Actually Means for Your Career

The IF matters because it signals placement within the Cell Press hierarchy.

For postdocs: A Cell Reports paper is a clear positive signal in biology job searches. It tells hiring committees you can publish within the Cell Press ecosystem. It's not Cell, but one Cell Reports plus two strong specialty journal papers is a competitive publication record for assistant professor applications.

For assistant professors: Cell Reports fits the "steady, visible productivity" narrative for tenure. The Cell Press brand helps even at IF 7.7, committees recognize the editorial standards.

For established labs: Cell Reports is the practical home for complete mechanistic stories that don't warrant a 12-month chase of Cell. Publishing efficiently at this level lets you maintain output while reserving the higher-tier push for the lab's strongest stories.

How Cell Reports Compares

Journal
2025 JIF
5-Year JIF
APC
Best for
Cell
45.1
50.7
$11,400 (OA option)
Field-defining mechanistic biology
Molecular Cell
16
17.6
$10,400 (OA option)
Deep molecular mechanisms
Cell Reports
7.7
7.7
$5,790
Focused biological insight, complete evidence
eLife
6.4
7.3
$3,000
Open biology, transparent review
PLOS Biology
6.9
7.2
$3,700
Broad biology, community focus
Nature Communications
18.1
18.9
$7,350
Cross-field significance
EMBO Journal
8.4
8.3
$5,200
European biology, molecular mechanisms

Cell Reports vs Cell: Cell JIF 45.1 requires field-defining biology, with research articles limited to seven figures and/or tables, and conceptual novelty that changes how a subfield thinks. Cell Reports rewards one focused insight with complete evidence. If the paper is strong but doesn't reshape a subfield, Cell Reports is the honest target.

Cell Reports vs Molecular Cell: Molecular Cell JIF 16 wants deeper stories with broader conceptual impact. If Molecular Cell desk-rejected your paper, Cell Reports is not a consolation, it's where single-insight structure fits best.

Cell Reports vs eLife: eLife dropped traditional accept/reject in 2023 and was delisted from SCIE. If your institution or committee needs a JIF, Cell Reports is safer. eLife is better if you value transparent review and zero APC.

What Reviewers Ask For at Cell Reports

Cell Reports reports a 5-day median to first editorial decision. If you clear the desk, here's what reviewers expect:

  1. Mechanistic completeness. The most common revision request. Reviewers expect a clear mechanistic chain from input to output. Correlation-only papers get sent back for rescue experiments.
  1. STAR Methods compliance. Cell Press's structured methods format is required for acceptance, and incomplete STAR Methods are a common request in revision.
  1. Quantification for every figure. Western blots need densitometry. Microscopy needs cell counts. Reviewers are stricter about this than at most comparable journals.
  1. Resource table completeness. Antibodies, cell lines, reagents, software with RRIDs and catalog numbers. Incomplete tables delay review.
  1. Graphical abstract quality. Cell Press requires one, and reviewers comment on it. A confusing graphical abstract signals the story isn't clear.

The Cell Press Transfer System

About 30-40% of Cell Reports papers arrive via transfer from Cell or Molecular Cell. When a flagship desk-rejects your paper, you can transfer the submission (including any reviews) directly through the Cell Press system.

This is not a downgrade path. Papers that were always better suited to Cell Reports often get smoother treatment on transfer because the editorial fit was there from the start. The key: reframe the cover letter for Cell Reports' audience. Don't just forward the Cell submission unchanged.

Strategic calculus: If your paper is borderline for Cell, submit there first. A Cell desk rejection costs ~4-7 days and gives you a clean transfer path. But if the paper is clearly Cell Reports-level, submitting directly signals honest calibration.

Readiness check

See how your manuscript scores against Cell Reports before you submit.

Run the scan with Cell Reports as your target journal. Get a fit signal alongside the IF context.

Check my manuscript fitPrivate API processing. Your manuscript is not used to train models.Open Cell Reports guide

What Pre-Submission Reviews Reveal About Cell Reports Submissions

For manuscripts targeting Cell Reports, three recurring patterns explain the majority of desk rejections.

Incomplete mechanistic story without orthogonal validation. Cell Reports names "new biological insight" as its primary criterion for publication across the life sciences. The most common desk-rejection pattern: papers that identify an association (X correlates with Y) and use one experimental approach to show directionality but do not demonstrate mechanism with orthogonal evidence.

A genetic perturbation (siRNA or CRISPR knockdown) without a rescue experiment, or a pharmacological inhibition result without a genetic validation, fails to meet the completeness bar. Cell Press editors pattern-match on this immediately from the abstract: the mechanism must be shown, not inferred.

STAR Methods and key resources table incompleteness. Cell Reports requires the STAR Methods format, with a standardized key resources table, for acceptance. The table summarizes the materials and resources essential to reproduce the results, and Cell Press highly recommends RRIDs as the identifiers for antibodies and model organisms. The most common compliance failure: cell line sources listed without catalog numbers, antibodies without RRID identifiers, and software versions omitted.

Reviewers and editors can catch these gaps during review, and the format is required for acceptance. The resource table is a transparency requirement.

Abstract that describes findings sequentially rather than communicating biological significance. In our experience editors often form a view quickly from the abstract and figures. The abstract should communicate why the results matter for the field, not just what was found.

Papers where the abstract reads as a sequential results summary ("We found X, then Y, then Z") without an explicit statement of what changes in biological understanding fail to pass the desk screen within the median 5-day decision window. The edit that moves a Cell Reports manuscript from desk rejection to review: rewriting the last 2-3 sentences of the abstract to state the specific insight the field gains, not the study's design or methodology.

A Cell Reports abstract check can assess whether the biological insight is stated explicitly enough for Cell Press's 5-day median first-decision triage and whether the STAR Methods section meets Cell Press compliance requirements.

Submit If / Think Twice If

Submit if:

  • The paper has one clean biological insight with complete mechanistic support
  • The evidence package is finished, reviewers will refine, not rescue
  • The work benefits from broad life-science visibility rather than narrow specialist readership
  • You want Cell Press editorial standards and the fast 5-day median first decision

Think twice if:

  • The paper could genuinely clear Cell or Molecular Cell (try there first, free cascade)
  • The work is mostly descriptive without a new mechanistic point
  • A strong specialty journal would reach the right readers more efficiently
  • The $5,790 APC is prohibitive and PLOS Biology ($3,700) or eLife ($3,000) covers similar ground

If any of the 'think twice' flags apply, a Cell Reports fit check identifies whether the biological insight, STAR Methods completeness, and APC trade-off make this the right venue for this manuscript.

How this page was created

This page was created from Clarivate's 2026 JCR release metrics, Cell Reports author guidance, Cell Press STAR Methods and Key Resources Table requirements, Scopus metric checks, SciRev author reports, and our pre-submission review work on Cell Press submissions. It covers the metric value, trend, ranking, and what the number means for submission strategy before choosing a target journal.

What the impact factor does not measure

Cell Reports at 7.7 JIF is below where Cell Press positioning would suggest, and the gap is informative. Five years ago the IF was 9.9; the drop tracks pandemic-citation normalization plus the general softening of mid-tier biology IFs as Nature Communications, eLife, and the open-access biology layer absorbed citation share. The 7.7 reads correctly when compared to the open-access biology cohort (eLife 6.4, Nature Communications 15.7) rather than to its own historical peak.

What 7.7 cannot show about Cell Reports editorial selection: roughly 60% of accepted papers route in from Cell or Cell Press flagship rejections, which means editorial standards are anchored to Cell's mechanistic-completeness bar minus the field-reshaping requirement. The $5,790 APC reflects this positioning, not journal-level cost recovery. Subfield prestige concentrates in cell biology and developmental biology subtopics where complete mechanistic stories dominate.

Before choosing Cell Reports based on IF alone, a Cell Reports scope check assesses whether the biological insight and mechanistic support meet Cell Press's editorial standard at this tier.

For examples of how Manusights surfaces Cell Press fit, STAR Methods, and mechanistic-completeness risks before submission, review the sample reports.

Turnaround varies by article type at this journal: Cell Reports Impact Factor review timeline.

If your submission has moved to a new status, here is how to read Cell Reports Impact Factor status labels.

Frequently asked questions

7.7 (2025 JIF, 2026 JCR release), with a five-year JIF of 8.1. Q1, rank 44/204 in Cell Biology. CiteScore is 12.9, SJR 3.796, h-index 246.

Cell Reports dropped from 9.9 (2021) to the current 7.7 as post-pandemic citation patterns normalized. This follows the same pattern across virtually all life science journals. The current 7.7 is the operative number for submission decisions.

Cell JIF 45.1 publishes field-defining discoveries requiring conceptual novelty across biology. Cell Reports JIF 7.7 publishes complete, mechanistic papers with a single clear biological insight.

Approximately $5,790 USD. Cell Reports is fully gold open access within the Cell Press portfolio.

Median 5 days to first editorial decision and 22 days from acceptance to online publication (Cell Press). ScienceDirect journal insights list a median of 37 days to decision after review and a submission-to-acceptance median; check that page for the current figures.

Approximately 14% (estimated). The 5-day median to first editorial decision means editors triage quickly. The journal publishes about 1,338 articles per year.

CiteScore 12.9 and SJR 3.796 (Scopus 2024), both Q1. The CiteScore running well above the two-year IF (12.9 vs 7.7) reflects the longer citation window capturing Cell Reports' durable citation tail in biology.

References

Sources

  1. Cell Reports journal homepage, Cell Press.
  2. Cell Reports author guidelines, Cell Press.
  3. Cell Reports submit manuscript, Cell Press.
  4. What do you look for in a paper?, Cell Press CrossTalk.
  5. Clarivate Journal Citation Reports (2026 release, reflecting 2025 data).
  6. Scopus journal metrics (CiteScore, SJR).
  7. SciRev community-reported author experience data.

Before you upload

Want the full picture on Cell Reports?

Scope, selectivity, what editors want, common rejection reasons, and submission context, all in one place.

These pages attract evaluation intent more than upload-ready intent.

Private API processing. Your manuscript is not used to train models.

Put the guidance to work

Build a journal decision from more than one signal.

Use comparison data as a starting point, then confirm the live source that governs the actual submission decision.

Internal navigation

Where to go next